May 20, 2020
Bayer Canada and PHRI partner on COVID-19 research
PHRI and the Canadian arm of Bayer have committed $0.5-million and $1.5-million respectively to initiate a major clinical research program:...
Read More
May 14, 2020
Staff stories from the lockdown
In early May 2020, PHRI asked their staff to show us how they were staying connected with their fellow employees...
Read More
March 22, 2020
ASA recommendations in Canadian stroke guidelines
PHRI scientists Shamir Mehta and Mike Sharma are among the coauthors of the Canadian Stroke Best Practice Recommendations, seventh edition:...
Read More
March 19, 2020
Research fellow discusses mentorship and training
PHRI research fellow Isabelle Johansson sat down recently to chat with scientist Darryl Leong (one of her informal mentors at...
Read More
March 10, 2020
4th Annual Janice Pogue Lectureship in Biostatistics
The Promise and Pitfalls of Stepped Wedge Cluster Randomized Trials Dr. Monica Taljaard, Senior Scientist, Ottawa Hospital Research Institute, and...
Read More
February 25, 2020
FDA indication reflects REWIND findings
FDA has approved dulaglutide for reducing the risk of major adverse cardiovascular events (cardiovascular death, non-fatal myocardial infarction, or non-fatal...
Read More